Bone turnover markers and sex hormones in men with idiopathic osteoporosis

European Journal of Clinical Investigation

Volumn 31, Issue 5, 2001, Pages 444-451

  Pietschmann, Peter ^a,b,e   Kudlacek, S ^c   Grisar, J ^a   Spitzauer, S ^a   Woloszczuk, W ^d   Willvonseder, R ^b,c   Peterlik, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^d Ludwig Boltzmann I of E E   (Austria)

^e Krankenhaus Barmherzige Brüder ^*  (Austria)

Author keywords

C terminal telopeptide of type I collagen; Deoxypyridinoline; Estradiol; Men; Osteoporosis; Sex hormone binding globulin

Indexed keywords

ANDROGEN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; CREATININE; DEOXYPYRIDINOLINE; ESTRADIOL; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SIALOPROTEIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE METABOLISM; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0035012717     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00836.x     Document Type: Article

References (42)

1. 1 Anonymous. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1991;90:107-10.
2. 2 Mann T, Oviatt SK, Wilson D, Nelson D, Orwoll ES. Vertebral deformity in men. J Bone Miner Res 1992;7: 1259-65.
3. 3 O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. J Bone Miner Res 1996;11:1010-8.
4. 4 Melton LJ, O'Fallon M, Riggs BL. Secular trends in the incidence of hip fractures. Calcif Tissue Int 1987;41:57-64.
5. 5 Seeman E, Melton LJ, O'Fallon M, Riggs BL. Risk factors for osteoporosis in men. Am J Med 1983;75:977-83.
6. 6 Francis RM, Peacock M, Marshall DH, Horsman A, Aaron JE. Spinal osteoporosis in men. Bone Mineral 1989;5:347-57.
7. 7 Graninger M, Dirnberger E, Kainberger F, Bernecker P, Graninger W, Smolen J et al. Comparison of spinal and femoral dual energy X-ray absorptiometry (DXA) in men with primary and secondary osteoporosis. Osteologie 1998;7:48-52.
8. 8 Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987;106:354-61.
9. 9 Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989;69:523-7;.
10. 10 Murphy S, Khaw K, Cassidy A, Compston JE. Sex hormones and bone mineral density in elderly men. Bone Mineral 1993;20:133-40.
11. 11 Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res 1997;12:1833-43.
12. 12 Khosla S, Melton JL III, Atkinson AT, O'Fallon WM, Klee GG, Riggs LB. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1988;8:2266-74.
13. 13 Seeman E. Advances in the study of osteoporosis in men. In: Papapoulos SE, Lips P, Pols HAP, Johnston CC and Delmas PD editors. Osteoporosis'96 Amsterdam: Elsevier;1996. p.341-58.
14. 14 Garnero P, Delmas P. Measurements of Biochemical Markers: Methods and Limitations. In: Bilezikian JP, Raisz L, Rodan G editors. Principles of bone biology. San Diego: Academic Press;1996.p.1277-92.
15. 15 Seibl MJ, Pols HAP. Clinical Application of Biochemical Markers of Bone Metabolism. In: Bilezikian JP, Raisz L, Rodan G editors. Principles of bone biology. San Diego: Academic press;1996.p.1293-313.
16. 16 Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639-44.
17. 17 Hanson D, Weis MAE, Bollen AM, Maslan SH, Singer FE, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
18. 18 Garnero P, Gineyts E, Riou JP, Delmas PD. Assesement of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994;79:780-5.
19. 19 Christgau S, Rosenquist C., Alexandersen P, Bjarnason NH, Ravu P, Fledius C et al. Clinical evaluation of the serum crosslaps one step ELISA, a new assay measuring the serum concentration of bone derived degradation products of type I collagen C-telopeptides. Clin Chem 1998;44:2290-300.
20. 20 Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R et al. Novel serum markers of bone resorption: clinical assesment and comparsion with established urinary indices. J Bone Miner Res 1999;14:792-801.
21. 21 Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparsion of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
22. 22 Risteli J, Risteli L. Assays of type I procollagen domains and collagen fragments: Problems to be solved and future trends. Scand J Clin Lab Invest 1997;57(Suppl.):105-13.
23. 23 Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R. Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 1992;22:542-5.
24. 24 Eyre DR. Bone biomarkers as tools in osteoporosis management. Spine 1997;24S:17S-24S.
25. 25 Robey PG. Bone Matrix Proteoglycans and Glycoproteins. In: Bilezikian JP, Raisz L, Rodan G editors. Principles of bone biology. San Diego: Academic Press;1996.p.155-66.
26. 26 Riminucci M, Bradbeer JN, Corsi A, Gentili C, Descalzi F, Cancedda R et al. Vis a vis cells and the priming of bone formation. J Bone Miner Res 1998;13:1852-61.
27. 27 De Vernouil MC, Bielakoff J, Herve M, Guerius J, Hott M, Modrowski D et al. Evidence for defective osteoblastic function -A role for alcohol and tobacco consumption in osteoporosis in middle aged men. Clin Orthopaedics Related Res 1983;179:107-15.
28. 28 Jackson JA, Kleerkooper M, Parfitt M, Sudhaker Rao D, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987;65:53-8.
29. 29 Hills E, Dunstan CR, Wong SYP, Evans RA. Bone histology in young adult osteoporosis. J Clin Pathol 1989;42:391-7.
30. 30 Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporosis Int 1992;2:128-34.
31. 31 Perry HM, Fallon MD, Bergfeld M, Teitelbaum SL, Avioli LV. Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. Arch Intern Med 1982;142:1295-8.
32. 32 Nordin BEC, Aaron J, Speed R, Francis RM, Makins N. Bone formation and resorption as the determinants of trabecular bone Volume in normal and osteoporotic men. Scott Med J 1984;29:171-5.
33. 33 Bourdel A, Mahoudeau JA, Guaydier-Soquieres G, Leymarie P, Sabatier JP. Loyau. Etude de la function gonadique au cours de l'osteoporose masculine en apparence primitive. La Presse Med 1989 18:1691-5.
34. 34 Smith EP, Body J, Frank GR, Takahoashi H, Cohen RM, Specker B et al. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 1994 331:1056-61.
35. 35 Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. Sex steroids and bone mass in older men. J Clin Invest 1997 100:1755-9.
36. 36 Ongphiphadhanakul B, Rajatanavin R, Chanpraserthyothin S, Piaseu N, Chailurkit L. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 1998 49:803-9.
37. 37 Schiller C, Gruber R, Ho GM, Redlich K, Gober HJ, Katzgraber F et al. 17β-estradiol antagonizes effects of 1α, 25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures. Bone 1998 22:341-6.
38. 38 Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999 14:1061-6.
39. 39 Gillberg P, Johansson AG, Ljunghall S. Decreased estradiol levels and free androgen index and elevated sex hormone binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int 1999 64:209-13.
40. 40 Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Bone Miner Res 1999 104:1363-74.
41. 41 Anderson FH, Francis RM, Bishop DJ, Rawlings D. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Ageing 1997 26:359-65.
42. 42 Anderson FH, Francis RM, Peaston RT, Wastell HJ. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res 1997 12:472-8.